These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 18483232)

  • 81. Epidemiology of contrast material-induced nephropathy in the era of hydration.
    Balemans CE; Reichert LJ; van Schelven BI; van den Brand JA; Wetzels JF
    Radiology; 2012 Jun; 263(3):706-13. PubMed ID: 22535561
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Injection-associated pain in femoral arteriography: a European multicenter study comparing safety, tolerability, and efficacy of iodixanol and iopromide.
    Justesen P; Downes M; Grynne BH; Lang H; Rasch W; Seim E
    Cardiovasc Intervent Radiol; 1997; 20(4):251-6. PubMed ID: 9211770
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial.
    Tomsick TA; Foster LD; Liebeskind DS; Hill MD; Carrozella J; Goyal M; von Kummer R; Demchuk AM; Dzialowski I; Puetz V; Jovin T; Morales H; Palesch YY; Broderick J; Khatri P; Yeatts SD;
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2074-81. PubMed ID: 26228892
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
    Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
    AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Renal failure in 57 925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media.
    Liss P; Persson PB; Hansell P; Lagerqvist B
    Kidney Int; 2006 Nov; 70(10):1811-7. PubMed ID: 17003814
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [A prospective study on the effects of low-osmolar and nonionic contrast media on renal functions].
    Liu Y; Yang F; Hu G
    Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):733-6. PubMed ID: 11930676
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
    Budhiraja P; Chen Z; Popovtzer M
    Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients.
    Erley CM; Bader BD; Berger ED; Tuncel N; Winkler S; Tepe G; Risler T; Duda S
    Nephrol Dial Transplant; 2004 Oct; 19(10):2526-31. PubMed ID: 15280530
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures.
    Briguori C; Colombo A; Airoldi F; Melzi G; Michev I; Carlino M; Montorfano M; Chieffo A; Bellanca R; Ricciardelli B
    Catheter Cardiovasc Interv; 2006 Feb; 67(2):175-80. PubMed ID: 16400668
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide.
    Pugh ND; Sissons GR; Ruttley MS; Berg KJ; Nossen JO; Eide H
    Clin Radiol; 1993 Feb; 47(2):96-9. PubMed ID: 8435972
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.
    Chou SH; Wang ZJ; Kuo J; Cabarrus M; Fu Y; Aslam R; Yee J; Zimmet JM; Shunk K; Elicker B; Yeh BM
    Eur J Radiol; 2011 Nov; 80(2):378-86. PubMed ID: 21470810
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
    Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
    Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
    Wessely R; Koppara T; Bradaric C; Vorpahl M; Braun S; Schulz S; Mehilli J; Schömig A; Kastrati A;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):430-7. PubMed ID: 20031753
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship.
    Limbruno U; Picchi A; Micheli A; Calabria P; Cortese B; Brizi G; Severi S; De Caterina R
    J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):587-94. PubMed ID: 23811842
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The effects of the iodinated X-ray contrast media iodixanol, iohexol, iopromide, and ioversol on the rat kidney epithelial cell line NRK 52-E.
    Jensen H; Doughty RW; Grant D; Myhre O
    Ren Fail; 2011; 33(4):426-33. PubMed ID: 21529272
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Acute kidney damage induced by low- and iso-osmolar contrast media in rats: Comparison study with physiologic MRI and histologic-gene examination.
    Wu CJ; Bao ML; Wang Q; Wang XN; Liu XS; Shi HB; Zhang YD
    J Magn Reson Imaging; 2017 Jan; 45(1):291-302. PubMed ID: 27367527
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Low-osmolar monomeric versus iso-osmolar dimeric contrast media: an intra-individual comparison in CT angiography using an animal model.
    Behrendt FF; Pietsch H; Jost G; Keil S; Mottaghy FM; Günther RW; Mahnken AH
    J Med Imaging Radiat Oncol; 2011 Apr; 55(2):170-5. PubMed ID: 21501406
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Incidence of Contrast-Induced Nephropathy After Renal Graft Catheter Arteriography Using Iodine-Based Contrast Medium.
    Fananapazir G; Troppmann C; Corwin MT; Bent CK; Vu CT; Lamba R
    AJR Am J Roentgenol; 2016 Apr; 206(4):783-6. PubMed ID: 26866337
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
    Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of iodixanol and ioxilan on QT interval and renal function in patients with systolic heart failure.
    Chow SL; Ng TM; Litwinski RA; Kangavari S; Weiss M
    Int J Cardiol; 2012 Jan; 154(1):17-21. PubMed ID: 20870304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.